{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:11:39Z","timestamp":1784304699374,"version":"3.55.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12035-022-02727-4","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T23:02:20Z","timestamp":1641769340000},"page":"1589-1603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["MicroRNAs in the pathophysiology of Alzheimer\u2019s disease and Parkinson's disease: an overview"],"prefix":"10.1007","volume":"59","author":[{"given":"Mohammad Rafi","family":"Khezri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naime Majidi","family":"Zolbanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5672-9202","authenticated-orcid":false,"given":"Morteza","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,9]]},"reference":[{"issue":"4","key":"2727_CR1","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10(4):a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10159","key":"2727_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789\u20131858","journal-title":"Lancet"},{"key":"2727_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L et al (2020) Prevalence of Alzheimer\u2019s Disease and Parkinson\u2019s Disease in China: An Updated Systematical Analysis. Front Aging Neurosci 12:476","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"2727_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust W (2018) Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci 19(11):687\u2013700","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2727_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"2727_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","volume":"699","author":"M de Planell-Saguer","year":"2011","unstructured":"de Planell-Saguer M, Rodicio MC (2011) Analytical aspects of microRNA in diagnostics: a review. Anal Chim acta 699(2):134\u2013152","journal-title":"Anal Chim acta"},{"issue":"3","key":"2727_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tig.2006.01.003","volume":"22","author":"VN Kim","year":"2006","unstructured":"Kim VN, Nam J-W (2006) Genomics of microRNA. Trends Genet 22(3):165\u2013173","journal-title":"Trends Genet"},{"issue":"5543","key":"2727_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.1065062","volume":"294","author":"NC Lau","year":"2001","unstructured":"Lau NC et al (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294(5543):858\u2013862","journal-title":"Science"},{"issue":"5543","key":"2727_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853\u2013858","journal-title":"Science"},{"issue":"10a","key":"2727_CR10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A et al (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10a):1902\u20131910","journal-title":"Genome Res"},{"issue":"9","key":"2727_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597\u2013610","journal-title":"Nat Rev Genet"},{"issue":"12","key":"2727_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nsmb1167","volume":"13","author":"GM Borchert","year":"2006","unstructured":"Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13(12):1097\u20131101","journal-title":"Nat Struct Mol Biol"},{"issue":"20","key":"2727_CR13","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20):4051\u20134060","journal-title":"EMBO J"},{"issue":"12","key":"2727_CR14","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1261\/rna.7135204","volume":"10","author":"X Cai","year":"2004","unstructured":"Cai X, Hagedorn CH, Cullen BR (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna 10(12):1957\u20131966","journal-title":"Rna"},{"issue":"6956","key":"2727_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature01957","volume":"425","author":"Y Lee","year":"2003","unstructured":"Lee Y et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415\u2013419","journal-title":"Nature"},{"issue":"7014","key":"2727_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature03120","volume":"432","author":"RI Gregory","year":"2004","unstructured":"Gregory RI et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432(7014):235\u2013240","journal-title":"Nature"},{"issue":"5654","key":"2727_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.1090599","volume":"303","author":"E Lund","year":"2004","unstructured":"Lund E et al (2004) Nuclear export of microRNA precursors. Science 303(5654):95\u201398","journal-title":"Science"},{"issue":"24","key":"2727_CR18","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1101\/gad.1158803","volume":"17","author":"R Yi","year":"2003","unstructured":"Yi R et al (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24):3011\u20133016","journal-title":"Genes Dev"},{"issue":"2","key":"2727_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1261\/rna.5167604","volume":"10","author":"MT Bohnsack","year":"2004","unstructured":"Bohnsack MT, Czaplinski K, G\u00f6rlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. Rna 10(2):185\u2013191","journal-title":"Rna"},{"issue":"5","key":"2727_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.molcel.2007.05.001","volume":"26","author":"L Peters","year":"2007","unstructured":"Peters L, Meister G (2007) Argonaute proteins: mediators of RNA silencing. Mol Cell 26(5):611\u2013623","journal-title":"Mol Cell"},{"issue":"1","key":"2727_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1750-3639.2007.00121.x","volume":"18","author":"X Liu","year":"2008","unstructured":"Liu X, Fortin K, Mourelatos Z (2008) MicroRNAs: biogenesis and molecular functions. Brain Pathol 18(1):113\u2013121","journal-title":"Brain Pathol"},{"issue":"2","key":"2727_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233","journal-title":"Cell"},{"issue":"35","key":"2727_CR23","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y et al (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6(35):37043","journal-title":"Oncotarget"},{"issue":"3","key":"2727_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000007969","volume":"40","author":"J-P Brion","year":"1998","unstructured":"Brion J-P (1998) Neurofibrillary tangles and Alzheimer\u2019s disease. Eur Neurol 40(3):130\u2013140","journal-title":"Eur Neurol"},{"issue":"2","key":"2727_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpsychires.2010.06.002","volume":"45","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV et al (2011) Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Psychiatr Res 45(2):220\u2013224","journal-title":"J Psychiatr Res"},{"issue":"19","key":"2727_CR26","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1073\/pnas.0500466102","volume":"102","author":"W Noble","year":"2005","unstructured":"Noble W et al (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci 102(19):6990\u20136995","journal-title":"Proc Natl Acad Sci"},{"key":"2727_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.10.027","volume":"819","author":"Z Tan","year":"2018","unstructured":"Tan Z et al (2018) Nimodipine attenuates tau phosphorylation at Ser396 via miR-132\/GSK-3\u03b2 pathway in chronic cerebral hypoperfusion rats. Eur J Pharmacol 819:1\u20138","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2727_CR28","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1002\/jcb.28276","volume":"120","author":"J Li","year":"2019","unstructured":"Li J et al (2019) miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3\u03b2 in Alzheimer\u2019s disease. J Cell Biochem 120(6):9936\u20139946","journal-title":"J Cell Biochem"},{"issue":"7","key":"2727_CR29","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","volume":"33","author":"X-H Li","year":"2012","unstructured":"Li X-H et al (2012) AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging 33(7):1400\u20131410","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2727_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1471-4159.2007.04642.x","volume":"102","author":"A Ozaita","year":"2007","unstructured":"Ozaita A, Puighermanal E, Maldonado R (2007) Regulation of PI3K\/Akt\/GSK-3 pathway by cannabinoids in the brain. J Neurochem 102(4):1105\u20131114","journal-title":"J Neurochem"},{"issue":"15","key":"2727_CR31","doi-asserted-by":"publisher","first-page":"24314","DOI":"10.18632\/oncotarget.15149","volume":"8","author":"Q Kang","year":"2017","unstructured":"Kang Q et al (2017) MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K\/Akt\/GSK3\u03b2 pathway in N2a\/APP695swe cells. Oncotarget 8(15):24314","journal-title":"Oncotarget"},{"issue":"38","key":"2727_CR32","doi-asserted-by":"publisher","first-page":"29336","DOI":"10.1074\/jbc.M110.101147","volume":"285","author":"JS Mohamed","year":"2010","unstructured":"Mohamed JS, Lopez MA, Boriek AM (2010) Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3\u03b2. J Biol Chem 285(38):29336\u201329347","journal-title":"J Biol Chem"},{"issue":"2","key":"2727_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3892\/mmr.2013.1534","volume":"8","author":"B Li","year":"2013","unstructured":"Li B, Sun H (2013) MiR-26a promotes neurite outgrowth by repressing PTEN expression. Mol Med Rep 8(2):676\u2013680","journal-title":"Mol Med Rep"},{"issue":"5733","key":"2727_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K et al (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733):476\u2013481","journal-title":"Science"},{"issue":"4","key":"2727_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","volume":"38","author":"W Noble","year":"2003","unstructured":"Noble W et al (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38(4):555\u2013565","journal-title":"Neuron"},{"key":"2727_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2017.09.043","volume":"661","author":"X Ma","year":"2017","unstructured":"Ma X, Liu L, Meng J (2017) MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer\u2019s disease. Neurosci Lett 661:57\u201362","journal-title":"Neurosci Lett"},{"key":"2727_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2016.12.015","volume":"51","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) Downregulation of miR-132\/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer\u2019s disease. Neurobiol Aging 51:156\u2013166","journal-title":"Neurobiol Aging"},{"issue":"21","key":"2727_CR38","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.15252\/embj.201797724","volume":"36","author":"C Li","year":"2017","unstructured":"Li C, G\u00f6tz J (2017) Somatodendritic accumulation of Tau in Alzheimer\u2019s disease is promoted by Fyn-mediated local protein translation. EMBO J 36(21):3120\u20133138","journal-title":"EMBO J"},{"issue":"2","key":"2727_CR39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","volume":"478","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao J, Lu G (2016) miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease. Biochem Biophys Res Commun 478(2):852\u2013857","journal-title":"Biochem Biophys Res Commun"},{"key":"2727_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fnagi.2019.00365","volume":"11","author":"X Yao","year":"2020","unstructured":"Yao X et al (2020) Loss of miR-369 promotes tau phosphorylation by targeting the fyn and Serine\/Threonine-protein kinase 2 signaling pathways in Alzheimer\u2019s disease mice. Front Aging Neurosci 11:365","journal-title":"Front Aging Neurosci"},{"issue":"1\u20133","key":"2727_CR41","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cbi.2008.04.049","volume":"175","author":"HY Zhang","year":"2008","unstructured":"Zhang HY et al (2008) Potential therapeutic targets of huperzine A for Alzheimer\u2019s disease and vascular dementia. Chemico-Biol Interact 175(1\u20133):396\u2013402","journal-title":"Chemico-Biol Interact"},{"issue":"2\u20133","key":"2727_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0960-0760(03)00043-8","volume":"84","author":"S Goodenough","year":"2003","unstructured":"Goodenough S, Sch\u00e4fer M, Behl C (2003) Estrogen-induced cell signalling in a cellular model of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol 84(2\u20133):301\u2013305","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2727_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.toxlet.2017.08.082","volume":"280","author":"X Du","year":"2017","unstructured":"Du X et al (2017) miR-124 downregulates BACE 1 and alters autophagy in APP\/PS1 transgenic mice. Toxicol Lett 280:195\u2013205","journal-title":"Toxicol Lett"},{"issue":"8","key":"2727_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10571-020-00823-4","volume":"40","author":"K Jash","year":"2020","unstructured":"Jash K et al (2020) MicroRNA-29b Modulates \u03b2-Secretase Activity in SH-SY5Y Cell Line and Diabetic Mouse Brain. Cell Mol Neurobiol 40(8):1367\u20131381","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"2727_CR45","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbrc.2009.12.051","volume":"391","author":"N Aoyagi","year":"2010","unstructured":"Aoyagi N et al (2010) PI3K inhibition causes the accumulation of ubiquitinated presenilin 1 without affecting the proteasome activity. Biochem Biophys Res Commun 391(2):1240\u20131245","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2727_CR46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.celrep.2014.09.037","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X et al (2014) Sorting nexin 27 regulates A\u03b2 production through modulating \u03b3-secretase activity. Cell Rep 9(3):1023\u20131033","journal-title":"Cell Rep"},{"issue":"6","key":"2727_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1567205016666190503145207","volume":"16","author":"D Liu","year":"2019","unstructured":"Liu D et al (2019) Inhibition of microRNA-155 alleviates cognitive impairment in Alzheimer\u2019s disease and involvement of neuroinflammation. Curr Alzheimer Res 16(6):473\u2013482","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"2727_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nm.3117","volume":"19","author":"X Wang","year":"2013","unstructured":"Wang X et al (2013) Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down\u2019s syndrome. Nat Med 19(4):473\u2013480","journal-title":"Nat Med"},{"issue":"3","key":"2727_CR49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","volume":"24","author":"JM Long","year":"2019","unstructured":"Long JM et al (2019) Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2032-untranslated region: Implications in Alzheimer\u2019s disease. Mol Psychiatry 24(3):345\u2013363","journal-title":"Mol Psychiatry"},{"key":"2727_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2011.10.051","volume":"1455","author":"C Liang","year":"2012","unstructured":"Liang C et al (2012) MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455:103\u2013113","journal-title":"Brain Res"},{"issue":"16","key":"2727_CR51","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.4161\/cc.7.16.6524","volume":"7","author":"GV Glinsky","year":"2008","unstructured":"Glinsky GV (2008) An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle 7(16):2570\u20132583","journal-title":"Cell Cycle"},{"issue":"1","key":"2727_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.4752","volume":"240","author":"CM Cheng","year":"2016","unstructured":"Cheng CM et al (2016) Up-regulation of miR-455-5p by the TGF-\u03b2\u2013SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. J Pathol 240(1):38\u201349","journal-title":"J Pathol"},{"issue":"12","key":"2727_CR53","doi-asserted-by":"publisher","first-page":"e0168284","DOI":"10.1371\/journal.pone.0168284","volume":"11","author":"JT Chang","year":"2016","unstructured":"Chang JT et al (2016) Identification of MicroRNAs as breast cancer prognosis markers through the cancer genome atlas. PLoS ONE 11(12):e0168284","journal-title":"PLoS ONE"},{"issue":"2","key":"2727_CR54","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3892\/or.2016.5318","volume":"37","author":"H Xi","year":"2017","unstructured":"Xi H et al (2017) hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10. Oncol Rep 37(2):961\u2013968","journal-title":"Oncol Rep"},{"issue":"1","key":"2727_CR55","first-page":"26","volume":"18","author":"F Diomede","year":"2017","unstructured":"Diomede F et al (2017) Cannabidiol modulates the expression of Alzheimer\u2019s disease-related genes in mesenchymal stem cells. Int J Mol Sci 18(1):26","journal-title":"Int J Mol Sci"},{"issue":"20","key":"2727_CR56","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1093\/hmg\/ddx295","volume":"26","author":"BK Singh","year":"2017","unstructured":"Singh BK et al (2017) Ube3a deficiency inhibits amyloid plaque formation in APPswe\/PS1\u03b4E9 mouse model of Alzheimer\u2019s disease. Hum Mol Genet 26(20):4042\u20134054","journal-title":"Hum Mol Genet"},{"key":"2727_CR57","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.12659\/MSM.893859","volume":"21","author":"L Song","year":"2015","unstructured":"Song L et al (2015) miR-375 modulates radiosensitivity of HR-HPV-positive cervical cancer cells by targeting UBE3A through the p53 pathway. Med Sci Monit 21:2210","journal-title":"Med Sci Monit"},{"issue":"2","key":"2727_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata N et al (2000) Identification of the major A\u03b2 1\u201342-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6(2):143\u2013150","journal-title":"Nat Med"},{"key":"2727_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2017.07.060","volume":"657","author":"H Zhang","year":"2017","unstructured":"Zhang H et al (2017) Meta-analysis of expression and function of neprilysin in Alzheimer\u2019s disease. Neurosci Lett 657:69\u201376","journal-title":"Neurosci Lett"},{"issue":"7","key":"2727_CR60","first-page":"3383","volume":"11","author":"T Chu","year":"2018","unstructured":"Chu T et al (2018) miR-26b inhibits total neurite outgrowth, promotes cells apoptosis and downregulates neprilysin in Alzheimer\u2019s disease. Int J clin Exp Pathol 11(7):3383","journal-title":"Int J clin Exp Pathol"},{"issue":"6","key":"2727_CR61","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1021\/bi901994d","volume":"49","author":"M-C Liao","year":"2010","unstructured":"Liao M-C, Van Nostrand WE (2010) Degradation of soluble and fibrillar amyloid \u03b2-protein by matrix metalloproteinase (MT1-MMP) in vitro. Biochemistry 49(6):1127\u20131136","journal-title":"Biochemistry"},{"issue":"1","key":"2727_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1039\/C5MB00718F","volume":"12","author":"MJ Dhanavade","year":"2016","unstructured":"Dhanavade MJ et al (2016) Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of A\u03b2 peptides. Mol bioSyst 12(1):162\u2013168","journal-title":"Mol bioSyst"},{"issue":"28\u201329","key":"2727_CR63","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1016\/j.febslet.2006.10.075","volume":"580","author":"T Sakamoto","year":"2006","unstructured":"Sakamoto T et al (2006) Aluminum inhibits proteolytic degradation of amyloid \u03b2 peptide by cathepsin D: a potential link between aluminum accumulation and neuritic plaque deposition. FEBS Lett 580(28\u201329):6543\u20136549","journal-title":"FEBS Lett"},{"issue":"2","key":"2727_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","volume":"35","author":"R Tiribuzi","year":"2014","unstructured":"Tiribuzi R et al (2014) miR128 up-regulation correlates with impaired amyloid \u03b2 (1\u201342) degradation in monocytes from patients with sporadic Alzheimer\u2019s disease. Neurobiol Aging 35(2):345\u2013356","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2727_CR65","first-page":"2373","volume":"18","author":"Y Jin","year":"2018","unstructured":"Jin Y, Tu Q, Liu M (2018) MicroRNA-125b regulates Alzheimer\u2019s disease through SphK1 regulation. Mol Med Rep 18(2):2373\u20132380","journal-title":"Mol Med Rep"},{"key":"2727_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2017.06.045","volume":"655","author":"C Zhou","year":"2017","unstructured":"Zhou C et al (2017) MicroRNA-144 modulates oxidative stress tolerance in SH-SY5Y cells by regulating nuclear factor erythroid 2-related factor 2-glutathione axis. Neurosci Lett 655:21\u201327","journal-title":"Neurosci Lett"},{"key":"2727_CR67","doi-asserted-by":"publisher","first-page":"113128","DOI":"10.1016\/j.expneurol.2019.113128","volume":"324","author":"G-D Wu","year":"2020","unstructured":"Wu G-D et al (2020) microRNA-592 blockade inhibits oxidative stress injury in Alzheimer\u2019s disease astrocytes via the KIAA0319-mediated Keap1\/Nrf2\/ARE signaling pathway. Exp Neurol 324:113128","journal-title":"Exp Neurol"},{"issue":"9","key":"2727_CR68","doi-asserted-by":"publisher","first-page":"15891","DOI":"10.1002\/jcb.28861","volume":"120","author":"Q Duan","year":"2019","unstructured":"Duan Q, Si E (2019) MicroRNA-25 aggravates A\u03b21-42-induced hippocampal neuron injury in Alzheimer\u2019s disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. J Cell Biochem 120(9):15891\u201315905","journal-title":"J Cell Biochem"},{"issue":"15","key":"2727_CR69","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/hmg\/ddt164","volume":"22","author":"H-KA Wong","year":"2013","unstructured":"Wong H-KA et al (2013) De-repression of FOXO3a death axis by microRNA-132 and-212 causes neuronal apoptosis in Alzheimer\u2019s disease. Hum Mol Genet 22(15):3077\u20133092","journal-title":"Hum Mol Genet"},{"issue":"4\u20135","key":"2727_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"X Wang","year":"2009","unstructured":"Wang X et al (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull 80(4\u20135):268\u2013273","journal-title":"Brain Res Bull"},{"key":"2727_CR71","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2015.05.021","volume":"1618","author":"CE Briggs","year":"2015","unstructured":"Briggs CE et al (2015) Midbrain dopamine neurons in Parkinson\u2019s disease exhibit a dysregulated miRNA and target-gene network. Brain Res 1618:111\u201321","journal-title":"Brain Res"},{"key":"2727_CR72","first-page":"211","volume-title":"Handbook of clinical neurology","author":"A Domingo","year":"2018","unstructured":"Domingo A, Klein C (2018) Genetics of Parkinson disease. Handbook of clinical neurology, vol 147. Elsevier, pp 211\u2013227"},{"issue":"1","key":"2727_CR73","first-page":"1","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W et al (2017) Parkinson disease. Nat Rev Dis Prim 3(1):1\u201321","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"2727_CR74","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA et al (2002) \u03b1-Synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J mol Biol 322(5):1089\u20131102","journal-title":"J mol Biol"},{"issue":"17","key":"2727_CR75","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of \u03b1-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201312734","journal-title":"J Biol Chem"},{"issue":"31","key":"2727_CR76","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1073\/pnas.0802437105","volume":"105","author":"CR Scherzer","year":"2008","unstructured":"Scherzer CR et al (2008) GATA transcription factors directly regulate the Parkinson\u2019s disease-linked gene \u03b1-synuclein. Proc Natl Acad Sci 105(31):10907\u201310912","journal-title":"Proc Natl Acad Sci"},{"key":"2727_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mcn.2013.09.002","volume":"57","author":"JA Wright","year":"2013","unstructured":"Wright JA et al (2013) Counter-regulation of alpha-and beta-synuclein expression at the transcriptional level. Mol Cell Neurosci 57:33\u201341","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"2727_CR78","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1182\/blood-2005-06-2516","volume":"107","author":"W Zhao","year":"2006","unstructured":"Zhao W et al (2006) Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase\/AKT signaling pathway. Blood 107(3):907\u2013915","journal-title":"Blood"},{"issue":"5","key":"2727_CR79","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1471-4159.2009.06250.x","volume":"110","author":"RL Clough","year":"2009","unstructured":"Clough RL, Dermentzaki G, Stefanis L (2009) Functional dissection of the \u03b1-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem 110(5):1479\u20131490","journal-title":"J Neurochem"},{"issue":"1","key":"2727_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01695-8","volume":"39","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p\/EGFR\/PI3K\/AKT\/c-MYC feedback loop. J Exp Clin Cancer Res 39(1):1\u201320","journal-title":"J Exp Clin Cancer Res"},{"key":"2727_CR81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2017.09.065","volume":"661","author":"G Je","year":"2017","unstructured":"Je G, Kim Y-S (2017) Mitochondrial ROS-mediated post-transcriptional regulation of \u03b1-synuclein through miR-7 and miR-153. Neurosci Lett 661:132\u2013136","journal-title":"Neurosci Lett"},{"issue":"4","key":"2727_CR82","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601\u2013607","journal-title":"Neuron"},{"key":"2727_CR83","doi-asserted-by":"crossref","unstructured":"Verma M, Steer EK, Chu CT (2014) ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta (BBA)-Mol Basis Dis 1842(8):1273\u20131281","DOI":"10.1016\/j.bbadis.2013.11.005"},{"issue":"7306","key":"2727_CR84","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke S et al (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466(7306):637\u2013641","journal-title":"Nature"},{"issue":"1","key":"2727_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2008.07.053","volume":"443","author":"M Guerraz","year":"2008","unstructured":"Guerraz M, Bronstein AM (2008) Mechanisms underlying visually induced body sway. Neurosci Lett 443(1):12\u201316","journal-title":"Neurosci Lett"},{"issue":"3","key":"2727_CR86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"HJ Cho","year":"2013","unstructured":"Cho HJ et al (2013) MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22(3):608\u2013620","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2727_CR87","first-page":"724","volume":"23","author":"Q Wu","year":"2019","unstructured":"Wu Q, Xi D, Wang Y (2019) MicroRNA-599 regulates the development of Parkinson\u2019s disease through mediating LRRK2 expression. Eur Rev Med Pharmacol Sci 23(2):724\u2013731","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2727_CR88","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3389\/fcell.2021.661461","volume":"9","author":"SR Oliveira","year":"2021","unstructured":"Oliveira SR et al (2021) miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson\u2019s Disease. Front Cell Dev Biol 9:1521","journal-title":"Front Cell Dev Biol"},{"key":"2727_CR89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fnmol.2019.00105","volume":"12","author":"W Xu","year":"2019","unstructured":"Xu W et al (2019) Sodium benzoate attenuates secondary brain injury by inhibiting neuronal apoptosis and reducing mitochondria-mediated oxidative stress in a rat model of intracerebral hemorrhage: Possible involvement of DJ-1\/Akt\/IKK\/NF\u03baB pathway. Front Mol Neurosci 12:105","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"2727_CR90","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10571-014-0126-x","volume":"35","author":"H Zou","year":"2015","unstructured":"Zou H et al (2015) MicroRNA-29c\/PTEN pathway is involved in mice brain development and modulates neurite outgrowth in PC12 cells. Cell Mol Neurobiol 35(3):313\u2013322","journal-title":"Cell Mol Neurobiol"},{"key":"2727_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","volume":"156","author":"N Filipczak","year":"2020","unstructured":"Filipczak N et al (2020) Recent advancements in liposome technology. Adv Drug Deliv Rev 156:4\u201322","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2727_CR92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1566523218666180430121323","volume":"18","author":"R Titze-de-Almeida","year":"2018","unstructured":"Titze-de-Almeida R, Titze-de-Almeida SS (2018) miR-7 replacement therapy in Parkinson\u2019s disease. Curr Gene Ther 18(3):143\u2013153","journal-title":"Curr Gene Ther"},{"issue":"9","key":"2727_CR93","doi-asserted-by":"publisher","first-page":"14995","DOI":"10.1002\/jcb.28761","volume":"120","author":"XH Zhao","year":"2019","unstructured":"Zhao XH et al (2019) MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson\u2019s disease. J Cell Biochem 120(9):14995\u201315006","journal-title":"J Cell Biochem"},{"issue":"11","key":"2727_CR94","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS et al (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122(11):1630\u20131637","journal-title":"Br J Cancer"},{"issue":"4","key":"2727_CR95","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1002\/jcp.29296","volume":"235","author":"T Chen","year":"2020","unstructured":"Chen T et al (2020) Circular RNA circC3P1 restrains kidney cancer cell activity by regulating miR-21\/PTEN axis and inactivating PI3K\/AKT and NF-kB pathways. J Cell Physiol 235(4):4001\u20134010","journal-title":"J Cell Physiol"},{"key":"2727_CR96","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2016.05.011","volume":"1644","author":"C Su","year":"2016","unstructured":"Su C, Yang X, Lou J (2016) Geniposide reduces \u03b1-synuclein by blocking microRNA-21\/lysosome-associated membrane protein 2A interaction in Parkinson disease models. Brain Res 1644:98\u2013106","journal-title":"Brain Res"},{"key":"2727_CR97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2018.03.041","volume":"675","author":"W Li","year":"2018","unstructured":"Li W et al (2018) MiR-181b regulates autophagy in a model of Parkinson\u2019s disease by targeting the PTEN\/Akt\/mTOR signaling pathway. Neurosci Lett 675:83\u201388","journal-title":"Neurosci Lett"},{"key":"2727_CR98","doi-asserted-by":"publisher","first-page":"107900","DOI":"10.1016\/j.neuropharm.2019.107900","volume":"164","author":"RM Salama","year":"2020","unstructured":"Salama RM et al (2020) Neuroprotective effect of crocin against rotenone-induced Parkinson\u2019s disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology 164:107900","journal-title":"Neuropharmacology"},{"issue":"1","key":"2727_CR99","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1080\/21691401.2019.1636805","volume":"47","author":"T Peng","year":"2019","unstructured":"Peng T et al (2019) Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson\u2019s disease via regulating miR-100\/ATG10 axis and PI3K\/Akt\/mTOR pathway activation. Artif Cells Nanomed Biotechnol 47(1):2764\u20132774","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"7","key":"2727_CR100","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","volume":"35","author":"W Kim","year":"2014","unstructured":"Kim W et al (2014) miR-126 contributes to Parkinson\u2019s disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling. Neurobiol Aging 35(7):1712\u20131721","journal-title":"Neurobiol Aging"},{"key":"2727_CR101","doi-asserted-by":"crossref","unstructured":"Qin X, et al. (2021) MicroRNA-185 activates PI3K\/AKT signaling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson\u2019s disease. J Drug Target 1\u20139","DOI":"10.1080\/1061186X.2021.1886300"},{"key":"2727_CR102","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yexmp.2019.05.002","volume":"109","author":"H Ge","year":"2019","unstructured":"Ge H et al (2019) MiR-410 exerts neuroprotective effects in a cellular model of Parkinson\u2019s disease induced by 6-hydroxydopamine via inhibiting the PTEN\/AKT\/mTOR signaling pathway. Exp Mol Pathol 109:16\u201324","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"2727_CR103","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","volume":"69","author":"G Mudo","year":"2012","unstructured":"Mudo G et al (2012) Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson\u2019s disease. Cell Mol Life Sci 69(7):1153\u20131165","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2727_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-3-2","volume":"3","author":"J M\u00e4kel\u00e4","year":"2014","unstructured":"M\u00e4kel\u00e4 J et al (2014) Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1. Springerplus 3(1):1\u201312","journal-title":"Springerplus"},{"issue":"3","key":"2727_CR105","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/oby.22376","volume":"27","author":"N Wang","year":"2019","unstructured":"Wang N et al (2019) Fibroblast growth factor 21 exerts its anti-inflammatory effects on multiple cell types of adipose tissue in obesity. Obesity 27(3):399\u2013408","journal-title":"Obesity"},{"issue":"10","key":"2727_CR106","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/dneu.20506","volume":"67","author":"J Peltier","year":"2007","unstructured":"Peltier J, O\u2019Neill A, Schaffer DV (2007) PI3K\/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67(10):1348\u20131361","journal-title":"Dev Neurobiol"},{"key":"2727_CR107","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/DDDT.S188436","volume":"13","author":"Y Tu","year":"2019","unstructured":"Tu Y et al (2019) Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1\/2\/CREB\/BDNF signaling pathways. Drug Des Dev Ther 13:695","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"2727_CR108","doi-asserted-by":"publisher","first-page":"e104247","DOI":"10.1371\/journal.pone.0104247","volume":"9","author":"Z Liu","year":"2014","unstructured":"Liu Z et al (2014) Ethanol suppresses PGC-1\u03b1 expression by interfering with the cAMP-CREB pathway in neuronal cells. PLoS ONE 9(8):e104247","journal-title":"PLoS ONE"},{"issue":"21","key":"2727_CR109","first-page":"11192","volume":"24","author":"L Dong","year":"2020","unstructured":"Dong L et al (2020) MiR-133b inhibits MPP+-induced apoptosis in Parkinson\u2019s disease model by inhibiting the ERK1\/2 signaling pathway. Eur Rev Med Pharmacol Sci 24(21):11192\u201311198","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2727_CR110","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1128\/MCB.01204-10","volume":"31","author":"P Rada","year":"2011","unstructured":"Rada P et al (2011) SCF\/\u03b2-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol 31(6):1121\u20131133","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2727_CR111","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/BST20150011","volume":"43","author":"JD Hayes","year":"2015","unstructured":"Hayes JD et al (2015) Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of \u03b2-TrCP and GSK-3. Biochem Soc Trans 43(4):611\u2013620","journal-title":"Biochem Soc Trans"},{"key":"2727_CR112","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fncel.2015.00209","volume":"9","author":"B Alural","year":"2015","unstructured":"Alural B et al (2015) Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell Neurosci 9:209","journal-title":"Front Cell Neurosci"},{"key":"2727_CR113","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2019.08.024","volume":"143","author":"X-Z Xu","year":"2019","unstructured":"Xu X-Z et al (2019) Targeting Keap1 by miR-626 protects retinal pigment epithelium cells from oxidative injury by activating Nrf2 signaling. Free Radic Biol Med 143:387\u2013396","journal-title":"Free Radic Biol Med"},{"key":"2727_CR114","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jocn.2019.08.082","volume":"70","author":"L-X Qin","year":"2019","unstructured":"Qin L-X et al (2019) Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson\u2019s disease patients. J Clin Neurosci 70:198\u2013201","journal-title":"J Clin Neurosci"},{"issue":"8","key":"2727_CR115","first-page":"4179","volume":"11","author":"J Zhu","year":"2018","unstructured":"Zhu J et al (2018) Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway. Int J Clin Exp Pathol 11(8):4179","journal-title":"Int J Clin Exp Pathol"},{"key":"2727_CR116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J et al (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"key":"2727_CR117","doi-asserted-by":"crossref","unstructured":"Wang H-L et al. (2011) PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons. Biochim Biophys Acta (BBA)-Mol Basis Dis 1812(6):674\u2013684","DOI":"10.1016\/j.bbadis.2011.03.007"},{"issue":"6","key":"2727_CR118","doi-asserted-by":"publisher","first-page":"e2455","DOI":"10.1371\/journal.pone.0002455","volume":"3","author":"A Wood-Kaczmar","year":"2008","unstructured":"Wood-Kaczmar A et al (2008) PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE 3(6):e2455","journal-title":"PLoS ONE"},{"key":"2727_CR119","doi-asserted-by":"crossref","unstructured":"Furlong RM et al. (2019) The Parkinson's disease gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI (3, 4, 5) P3. J Cell Sci\u00a0132(20):jcs233221","DOI":"10.1242\/jcs.233221"},{"issue":"1","key":"2727_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-016-0121-4","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim J et al (2016) miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol neurodegener 11(1):1\u201316","journal-title":"Mol neurodegener"},{"issue":"2","key":"2727_CR121","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0278-5846(03)00019-8","volume":"27","author":"N Lev","year":"2003","unstructured":"Lev N, Melamed E, Offen D (2003) Apoptosis and Parkinson\u2019s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 27(2):245\u2013250","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"S3","key":"2727_CR122","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/ana.10489","volume":"53","author":"WG Tatton","year":"2003","unstructured":"Tatton WG et al (2003) Apoptosis in Parkinson\u2019s disease: signals for neuronal degradation. Ann Neurol 53(S3):S61\u2013S72","journal-title":"Ann Neurol"},{"key":"2727_CR123","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnmol.2018.00381","volume":"11","author":"S Sun","year":"2018","unstructured":"Sun S et al (2018) MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson\u2019s disease. Front Mol Neurosci 11:381","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"2727_CR124","first-page":"993","volume":"8","author":"S Li","year":"2016","unstructured":"Li S et al (2016) MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax and Sirt2. Am J Transl Res 8(2):993","journal-title":"Am J Transl Res"},{"issue":"1","key":"2727_CR125","first-page":"209","volume":"43","author":"J-X Gao","year":"2019","unstructured":"Gao J-X et al (2019) Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson\u2019s disease. Int J Mol Med 43(1):209\u2013220","journal-title":"Int J Mol Med"},{"key":"2727_CR126","doi-asserted-by":"publisher","first-page":"e922032","DOI":"10.12659\/MSM.922032","volume":"26","author":"W Lu","year":"2020","unstructured":"Lu W et al (2020) Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson\u2019s Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1). Med Sci Monit 26:e922032-1","journal-title":"Med Sci Monit"},{"key":"2727_CR127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2018.07.023","volume":"835","author":"J Zhu","year":"2018","unstructured":"Zhu J et al (2018) Inhibition of microRNA-505 suppressed MPP+-induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson\u2019s disease model. Eur J Pharmacol 835:11\u201318","journal-title":"Eur J Pharmacol"},{"key":"2727_CR128","first-page":"625","volume":"2015","author":"H Dong","year":"2015","unstructured":"Dong H et al (2015) (2018) Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Dis Mark 2015:625\u2013659","journal-title":"Dis Mark"},{"issue":"2","key":"2727_CR129","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-161179","volume":"57","author":"J Riancho","year":"2017","unstructured":"Riancho J et al (2017) MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimer Dis 57(2):483\u2013491","journal-title":"J Alzheimer Dis"},{"key":"2727_CR130","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuroscience.2020.02.044","volume":"432","author":"F Li","year":"2020","unstructured":"Li F et al (2020) Profile of pathogenic proteins and microRNAs in plasma-derived extracellular vesicles in Alzheimer\u2019s disease: a pilot study. Neuroscience 432:240\u2013246","journal-title":"Neuroscience"},{"issue":"1","key":"2727_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-019-0169-5","volume":"8","author":"A G\u00e1mez-Valero","year":"2019","unstructured":"G\u00e1mez-Valero A et al (2019) Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer\u2019s disease and dementia with Lewy bodies. Transl Neurodegener 8(1):1\u201317","journal-title":"Transl Neurodegener"},{"issue":"12","key":"2727_CR132","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1007\/s12035-018-1032-x","volume":"55","author":"PM McKeever","year":"2018","unstructured":"McKeever PM et al (2018) MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer\u2019s disease. Mol Neurobiol 55(12):8826\u20138841","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2727_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP et al (2008) Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimer Dis 14(1):27\u201341","journal-title":"J Alzheimer Dis"},{"issue":"1","key":"2727_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0501-4","volume":"11","author":"D Siedlecki-Wullich","year":"2019","unstructured":"Siedlecki-Wullich D et al (2019) Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer\u2019s disease. Alzheimer Res Ther 11(1):1\u201311","journal-title":"Alzheimer Res Ther"},{"issue":"10","key":"2727_CR135","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"\u00c1 Cheng","year":"2015","unstructured":"Cheng \u00c1 et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20(10):1188\u20131196","journal-title":"Mol Psychiatry"},{"key":"2727_CR136","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","volume":"13","author":"DJ Cha","year":"2019","unstructured":"Cha DJ et al (2019) miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients. Front Neurosci 13:1208","journal-title":"Front Neurosci"},{"issue":"8","key":"2727_CR137","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10571-020-00823-4","volume":"40","author":"K Jash","year":"2020","unstructured":"Jash K et al (2020) MicroRNA-29b Modulates \u03b2-Secretase Activity in SH-SY5Y Cell Line and Diabetic Mouse Brain. Cell Mol Neurobiol 40(8):1367\u20131381","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"2727_CR138","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","volume":"88","author":"H-C Zhu","year":"2012","unstructured":"Zhu H-C et al (2012) MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-\u03b2 production by targeting BACE1. Brain Res Bull 88(6):596\u2013601","journal-title":"Brain Res Bull"},{"key":"2727_CR139","doi-asserted-by":"crossref","unstructured":"Chopra N, et al. (2020) MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry 1\u201322","DOI":"10.1038\/s41380-019-0610-2"},{"key":"2727_CR140","doi-asserted-by":"crossref","unstructured":"Du W, Lei C, Dong Y (2021) MicroRNA-149 is downregulated in Alzheimer\u2019s disease and inhibits \u03b2-amyloid accumulation and ameliorates neuronal viability through targeting BACE1. Genet Mol Biol 44:1, e20200064","DOI":"10.1590\/1678-4685-gmb-2020-0064"},{"key":"2727_CR141","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuroscience.2021.03.028","volume":"463","author":"SN Hajjari","year":"2021","unstructured":"Hajjari SN et al (2021) MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer\u2019s Disease. Neuroscience 463:108\u2013115","journal-title":"Neuroscience"},{"issue":"5","key":"2727_CR142","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.7150\/thno.47408","volume":"11","author":"M-L Chen","year":"2021","unstructured":"Chen M-L et al (2021) Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer\u2019s disease by enhancing autophagy. Theranostics 11(5):2395","journal-title":"Theranostics"},{"issue":"53","key":"2727_CR143","doi-asserted-by":"publisher","first-page":"91551","DOI":"10.18632\/oncotarget.21177","volume":"8","author":"G Gong","year":"2017","unstructured":"Gong G et al (2017) miR-15b represses BACE1 expression in sporadic Alzheimer\u2019s disease. Oncotarget 8(53):91551","journal-title":"Oncotarget"},{"issue":"5","key":"2727_CR144","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s11011-019-00438-9","volume":"34","author":"Y Fu","year":"2019","unstructured":"Fu Y et al (2019) Intrahippocampal miR-342-3p inhibition reduces \u03b2-amyloid plaques and ameliorates learning and memory in Alzheimer\u2019s disease. Metab Brain Dise 34(5):1355\u20131363","journal-title":"Metab Brain Dise"},{"key":"2727_CR145","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","volume":"19","author":"AT Barros-Viegas","year":"2020","unstructured":"Barros-Viegas AT et al (2020) miRNA-31 improves cognition and abolishes amyloid-\u03b2 pathology by targeting APP and BACE1 in an animal model of alzheimer\u2019s disease. Mol Ther-Nucleic Acids 19:1219\u20131236","journal-title":"Mol Ther-Nucleic Acids"},{"key":"2727_CR146","doi-asserted-by":"crossref","unstructured":"Kumar S, et al. (2019) Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease. Biochim Biophys Acta (BBA)-Mol Basis Dis 1865(9):2428\u20132440","DOI":"10.1016\/j.bbadis.2019.06.006"},{"key":"2727_CR147","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s10529-020-02915-z","volume":"42","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chang Q (2020) MicroRNA miR-212 regulates PDCD4 to attenuate A\u03b2 25\u201335-induced neurotoxicity via PI3K\/AKT signaling pathway in Alzheimer\u2019s disease. Biotechnol Lett 42:1789\u20131797","journal-title":"Biotechnol Lett"},{"key":"2727_CR148","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fphar.2019.00806","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang L et al (2019) MicroRNA-200a-3p mediates neuroprotection in Alzheimer-related deficits and attenuates amyloid-beta overproduction and tau hyperphosphorylation via coregulating BACE1 and PRKACB. Front Pharmacol 10:806","journal-title":"Front Pharmacol"},{"issue":"1","key":"2727_CR149","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","volume":"209","author":"M Fang","year":"2012","unstructured":"Fang M et al (2012) The miR-124 regulates the expression of BACE1\/\u03b2-secretase correlated with cell death in Alzheimer\u2019s disease. Toxicol Lett 209(1):94\u2013105","journal-title":"Toxicol Lett"},{"issue":"6","key":"2727_CR150","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1159\/000484452","volume":"43","author":"L Han","year":"2017","unstructured":"Han L et al (2017) Maternally expressed gene 3 (MEG3) enhances PC12 cell hypoxia injury by targeting MiR-147. Cell Physiol Biochem 43(6):2457\u20132469","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"2727_CR151","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/abbs\/gmq026","volume":"42","author":"X Fan","year":"2010","unstructured":"Fan X et al (2010) miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin 42(5):318\u2013324","journal-title":"Acta Biochim Biophys Sin"},{"key":"2727_CR152","doi-asserted-by":"publisher","first-page":"135953","DOI":"10.1016\/j.neulet.2021.135953","volume":"756","author":"H Zhang","year":"2021","unstructured":"Zhang H et al (2021) Aberrant expression of miR-148a-3p in Alzheimer\u2019s disease and its protective role against amyloid-\u03b2 induced neurotoxicity. Neurosci Lett 756:135953","journal-title":"Neurosci Lett"},{"issue":"1","key":"2727_CR153","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5114\/fn.2020.94002","volume":"58","author":"C Sun","year":"2020","unstructured":"Sun C et al (2020) miR-143-3p inhibition promotes neuronal survival in an Alzheimer\u2019s disease cell model by targeting neuregulin-1. Folia Neuropathol 58(1):10\u201321","journal-title":"Folia Neuropathol"},{"issue":"1","key":"2727_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03887-3","volume":"7","author":"X Bai","year":"2017","unstructured":"Bai X et al (2017) Downregulation of blood serum microRNA 29 family in patients with Parkinson\u2019s disease. Sci Rep 7(1):1\u20137","journal-title":"Sci Rep"},{"issue":"8","key":"2727_CR155","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jnr.23377","volume":"92","author":"T Botta-Orfila","year":"2014","unstructured":"Botta-Orfila T et al (2014) Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson\u2019s disease. J Neurosci Res 92(8):1071\u20131077","journal-title":"J Neurosci Res"},{"issue":"5","key":"2727_CR156","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s00415-013-6900-8","volume":"260","author":"LF Cardo","year":"2013","unstructured":"Cardo LF et al (2013) Profile of microRNAs in the plasma of Parkinson\u2019s disease patients and healthy controls. J Neurol 260(5):1420\u20131422","journal-title":"J Neurol"},{"key":"2727_CR157","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2016.00036","volume":"8","author":"AG Hoss","year":"2016","unstructured":"Hoss AG et al (2016) microRNA profiles in Parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci 8:36","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"2727_CR158","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.0000000000001258","volume":"84","author":"A Serafin","year":"2015","unstructured":"Serafin A et al (2015) Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa\u2013treated patients with PD. Neurology 84(7):645\u2013653","journal-title":"Neurology"},{"key":"2727_CR159","unstructured":"Xie S, et al. (2020) Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson\u2019s disease. Int J Neurosci 1\u201316."},{"key":"2727_CR160","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.parkreldis.2016.09.028","volume":"33","author":"R Tatura","year":"2016","unstructured":"Tatura R et al (2016) Parkinson\u2019s disease: SNCA-, PARK2-, and LRRK2-targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord 33:115\u2013121","journal-title":"Parkinsonism Relat Disord"},{"key":"2727_CR161","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2016.06.061","volume":"629","author":"VD Nair","year":"2016","unstructured":"Nair VD, Ge Y (2016) Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson\u2019s disease striatum. Neurosci Lett 629:99\u2013104","journal-title":"Neurosci Lett"},{"key":"2727_CR162","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1155\/2021\/8814862","volume":"2021","author":"J Zhu","year":"2021","unstructured":"Zhu J et al (2021) Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3\u03b2\/\u03b2-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson\u2019s Disease. BioMed Res Int 2021:862\u2013873","journal-title":"BioMed Res Int"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02727-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02727-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02727-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:37:56Z","timestamp":1666636676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02727-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":162,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2727"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02727-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,9]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}